iressa tablet
astrazeneca canada inc - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents
apo-gefitinib tablet
apotex inc - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents
sandoz gefitinib tablet
sandoz canada incorporated - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents
nat-gefitinib tablet
natco pharma (canada) inc - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents
jamp gefitinib tablet
jamp pharma corporation - gefitinib - tablet - 250mg - gefitinib 250mg - antineoplastic agents
iressa 250 mg tab
مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - gefitinib 250 mg - 250 mg
gefitinib-teva fc tablet 250mg
teva pharmaceutical investments singapore pte. ltd. - gefitinib - tablet, film coated - gefitinib 250 mg
auro-gefitinib tablet
auro pharma inc - gefitinib - tablet - 250mg - gefitinib 250mg
gefitinib eg 250 mg film-coat. tabl.
eg sa-nv - gefitinib 250 mg - film-coated tablet - gefitinib
iressa
astrazeneca ab - gefitinib - carcinoma, non-small-cell lung - antineoplastic agents - iressa is indicated for the treatment of adult patients with locally advanced or metastatic non-small-cell lung cancer with activating mutations of epidermal-growth-factor-receptor tyrosine kinase.